The Swiss pharmaceutical firm says the acquisition would complement its current pipeline of therapies for neuromuscle problems.
Source link
Novartis Agrees to Acquire Avidity Biosciences for $12 Billion
Related Posts
Qualcomm announces AI chips to compete with AMD and Nvidia
Qualcomm introduced Monday that it’s going to launch new artificial intelligence accelerator chips, marking new competitors for Nvidia, which has…
Reddit (RDDT) stock pops on strong advertising and user growth
Reddit CEO Steve Huffman stands on the ground of the New York Inventory Change (NYSE) after ringing a bell on…
SoftBank in Talks to Invest Up to $30 Billion More in OpenAI
The Japanese conglomerate is exploring an extra funding as a part of the startup’s efforts to lift as much as…